News Breaks |
|
|
| September 20, 2012 |
| 08:01 EDT |  | SNY | Sanofi, TB Alliance announce collaboration to accelerate tuberculosis treatments
Sanofi and the Global Alliance for TB Drug Development announced a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis. Under the agreement, Sanofi and TB Alliance will collaborate to further optimize and develop several novel compounds in Sanofi's library that have demonstrated activity against Mycobacterium tuberculosis, the bacterium that causes TB. |
|
|
News For SNY From The Last 14 Days Check below for free stories on SNY the last two weeks. |
|
|
| May 17, 2013 |
| 08:03 EDT | | SNY | Sanofi reports positive topline results from pivotal Phase III Jakarta study
 Subscribe for More Information |
|
| 05:18 EDT | | SNY | Sanofi says JAK2 inhibitor for myelofibrosis met primary endpoint
Subscribe for More Information |
|
| May 15, 2013 |
| 15:16 EDT | | SNY | Sanofi systemic sclerosis treatment designated for orphan drug status
Subscribe for More Information |
|
| 05:39 EDT | | SNY | Sanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information |
|
| May 13, 2013 |
| 09:44 EDT |  | SNY | Several companies reportedly interested in buying Adcock Ingram, Globes says
Subscribe for More Information |
|
| 07:30 EDT |  | SNY | TechConnect to host a summit
2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. |
|
| May 10, 2013 |
| 11:48 EDT | | SNY | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| May 6, 2013 |
| 07:49 EDT | | SNY | Bernstein's global pharmaceuticals analyst has analyst/industry conference call
Subscribe for More Information |
|
|
|
|
|
